Aclaris Therapeutics ACRS
NASDAQ ACRS
$4.28 -0.13 (-2.83%)
As of: Oct 2, 2026 · 2:31 PM EDT

Aclaris Therapeutics (ACRS) Depreciation & Amortization (CF) (2014 - 2026)

Updated

Aclaris Therapeutics' Depreciation & Amortization (CF) was $107,000 in Q2 2026, down 6.1% from $114,000 a year earlier but up 4.9% from the prior quarter.

Analysis

Aclaris Therapeutics (ACRS) Depreciation & Amortization (CF) (2014 - 2026) Analysis & Trends

On a trailing twelve-month basis, Aclaris Therapeutics' Depreciation & Amortization (CF) was $421,000 through Jun 30, 2026, down 25.4% year-over-year; for FY2025, it was $454,000, down 43.7% from FY2024.

  • Depreciation & Amortization (CF) shows a five-year compound annual growth rate of -19.3% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $807,000 in FY2024 (-6.5%), $863,000 in FY2023 (+8.3%), $797,000 in FY2022 (-13.7%) and $923,000 in FY2021 (-30.3%).
  • Quarterly Depreciation & Amortization (CF) has moved between $102,000 (Q4 2025) and $243,000 (Q1 2024) over five years.
  • Compared with a year earlier, Depreciation & Amortization (CF) has declined for eight straight quarters, with an average decline of 31.2% over the last eight quarters.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q1 2024 (growth of 22.7%); the worst was Q3 2021 (a decline of 67.7%).
  • Per Business Quant data, ACRS's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $102,000 (Q1 2026), $102,000 (Q4 2025) and $110,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Aclaris Therapeutics 735.48 Mn 735.48 Mn 1.41 Mn 107,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 107,000.00
Mar 31, 2026 102,000.00
Dec 31, 2025 102,000.00
Sep 30, 2025 110,000.00
Jun 30, 2025 114,000.00
Mar 31, 2025 128,000.00
Dec 31, 2024 143,000.00
Sep 30, 2024 179,000.00
Jun 30, 2024 242,000.00
Mar 31, 2024 243,000.00
Dec 31, 2023 228,000.00
Sep 30, 2023 219,000.00
Jun 30, 2023 218,000.00
Mar 31, 2023 198,000.00
Dec 31, 2022 190,000.00
Sep 30, 2022 193,000.00
Jun 30, 2022 206,000.00
Mar 31, 2022 208,000.00
Dec 31, 2021 197,000.00
Sep 30, 2021 191,000.00
API Access

Aclaris Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ACRS&period=max&api_key=YOUR_API_KEY